Accord Clinical Research,LLC

Port Orange, Florida 32129

0 studies enrolling now · 25 studies all time

What they study most

Arthritis, Arthritis, Rheumatoid, Chronic Idiopathic Constipation, Chronic Low Back Pain, Chronic Pain, Colorectal Cancer, Diabetes Mellitus, Type 2, Diarrhea Predominant Irritable Bowel Syndrome, Eosinophilic Esophagitis (EoE), Gastroesophageal Reflux Disease, Hyperlipidemia, Hypertension

Studies at this site

• A Study in Adolescents and Adults With Eosinophilic Esophagitis (EoE) Measuring Histologic Response and Determine if Reduction in Dysphagia is Achieved — Completed
• Long-Term Analgesic Efficacy And Safety Of Tanezumab Alone Or In Combination With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Versus NSAIDs Alone In Patients With Osteoarthritis Of The Knee Or Hip — Stopped early
• Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD) — Completed
• Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen — Completed
• Tanezumab in Osteoarthritis Of The Hip — Completed
• Study of COV795 in Subjects With Osteoarthritis or Chronic Low Back Pain — Completed
• Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study — Completed
• Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone — Completed
• Long Term Safety and Efficacy Study of Tanezumab in Subjects With Osteoarthritis of the Hip or Knee — Completed
• Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone — Completed
• The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C) — Completed
• A Clinical Study in Patients With Overactive Bladder With Leakage of Urine, to Find Out if the Medicine, Fesoterodine, Works in Those Patients Who Did Not Have Enough Response to the Medicine, Tolterodine. — Completed
• 24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension — Completed
• Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events — Completed
• Efficacy and Safety Study of Buprenorphine HCl Buccal Film in Subjects With Low Back Pain — Completed
• PF-06372865 In Subjects With Chronic Low Back Pain — Completed
• Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP) — Completed
• Head to Head Study Epi proColon and FIT — Completed
• Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation — Completed
• Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) — Completed
• LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) — Completed
• A Study of 3 Doses of Dextofisopam in Females With Irritable Bowel Syndrome — Completed
• Rates of Gastric Ulcer by Endoscopy in Knee Osteoarthritis Patients Receiving LT-NS001 Versus Naprosyn® — Completed
• Study of LX1031 in Subjects With Non-Constipating Irritable Bowel Syndrome — Completed
• A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females — Status unconfirmed